CCR2, a leukocyte chemoattractant and known mediator in CAD, demonstrated a 3‐fold increase (p‐adj 3.6E‐04) in MI only IZ and 4.8‐fold increase (p‐adj 8.2E‐05) in MI + HPAC compared to control IZ. The gene discussed is CCR2; the disease is coronary artery disorder.